Rogelio Paniagua-Pérez

Dr. Rogelio Paniagua-Pérez

Bioquimica, Instituto Nacional de Rehabilitación, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2016 in African Journal of Traditional, Complementary and Alternative Medicines
Verified
Journal Article
Open access
PDF file
RPRogelio Paniagua-Pérez
Rogelio Paniagua-Pérez
GFGabriela Flores-Mondragón
Gabriela Flores-Mondragón
CRCelia Reyes-Legorreta
Celia Reyes-Legorreta
BHBrígida Herrera-López
Brígida Herrera-López
ICIsabel Cervantes-Hernández
Isabel Cervantes-Hernández
EMEduardo Madrigal-Santillán
Eduardo Madrigal-Santillán
EVALUATION OF THE ANTI-INFLAMMATORY CAPACITY OF BETA-SITOSTEROL IN RODENT ASSAYS

2 February 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
JIJeannett Izquierdo
Jeannett Izquierdo
JMJose A. Morales-González
Jose A. Morales-González
MSManuel Sanchez
Manuel Sanchez
GBGabriel Betanzos-Cabrera
Gabriel Betanzos-Cabrera
SDSara Marbelodet Sosa Delgado
Sara Marbelodet Sosa Delgado
EMEduardo Madrigal-Santillán
Eduardo Madrigal-Santillán
Cancer is one of the leading causes of deaths worldwide. The agents capable of causing damage to genetic material are known as genotoxins and, according to their mode of action, are classified into mutagens, carcinogens or teratogens. Genotoxins are involved in the pathogenesis of several chronic degenerative diseases including hepatic, neurodegenerative and cardiovascular disorders, diabetes, arthritis, cancer, chronic inflammation and ageing. In recent decades, researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens. Several studies have shown potential antigenotoxicity in a variety of fruits. In this review (Part 1), we present an overview of research conducted on some fruits (grapefruit, cranberries, pomegranate, guava, pineapple, and mango) which are frequentl consumed by humans, as well as the analysis of some phytochemicals extracted from fruits and yeasts which have demonstrated antigenotoxic capacity in various tests, including the Ames assay, sister chromatid exchange, chromosomal aberrations, micronucleus and comet assay.

21 May 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJuan Manuel García Cordero
Juan Manuel García Cordero
NMNikte Y. Martínez-Palma
Nikte Y. Martínez-Palma
EMEduardo B. Madrigal-Bujaidar
Eduardo B. Madrigal-Bujaidar
CJCristian Jiménez-Martínez
Cristian Jiménez-Martínez
EMEduardo Madrigal-Santillán
Eduardo Madrigal-Santillán
IAIsela Alvarez-Gonzalez
Isela Alvarez-Gonzalez
The present report was designed to determine the antioxidant and antigenotoxic effects of phaseolin (isolated from Phaseolus vulgaris) against mouse colon and liver damage induced by azoxymethane (AOM) and its colon chemopreventive effect. Eight groups with 12 mice each were utilized for an eight-week experiment: the control group was intragastrically (ig) administered 0.9% saline solution; the positive control group was intraperitoneally (ip) injected with 7.5 mg/kg AOM twice a week (weeks three and four of the experiment); three groups were ig administered each day with phaseolin (40, 200, and 400 mg/kg); and three groups were ig administered phaseolin daily (40, 200, and 400 mg/kg) plus 7.5 mg/kg AOM twice a week in weeks three and four of the experiment. The results showed that phaseolin did not produce oxidative stress, DNA damage, or aberrant crypts; in contrast, 100% inhibition of lipoperoxidation, protein oxidation, and nitrites induction generated by AOM was found in both organs, and DPPH radical capture occurred. The two highest phaseolin doses reduced DNA damage induced by AOM in both organs by more than 90% and reduced the AOM-induced aberrant crypts by 84%. Therefore, our study demonstrated the strong in vivo antioxidant, antigenotoxic, and chemopreventive potential of phaseolin.

24 July 2025 in Microorganisms
Verified
Journal Article
Open access
María Alejandra Samudio-CruzMaría Alejandra Samudio-Cruz
María Alejandra Samudio-Cruz
ALAlexandra Luna-Angulo
Alexandra Luna-Angulo
ECElizabeth Cabrera-Ruiz
Elizabeth Cabrera-Ruiz
CLCarlos Landa-Solis
Carlos Landa-Solis
EREdgar Rangel
Edgar Rangel
LSLaura Sanchez-Chapul
Laura Sanchez-Chapul
The role of the gut microbiota in obesity has been extensively studied worldwide, but research in Mexican populations is still limited. This is particularly important given the high obesity rates in Mexico, despite a traditional diet rich in diverse, plant-based foods. We conducted a systematic review of studies examining the gut microbiota in obese Mexican children and adults. The literature search was conducted in the Medline, CINAHL, SciELO, Redalyc and Web of Science databases. The included studies addressed topics such as obesity in different Mexican subgroups (e.g., adults, children, rural communities), dietary behaviors and interventions, traditional dietary patterns, and gut microbiota composition. Of the 2332 datasets, 19 studies met the inclusion criteria. These studies indicated that obesity in Mexican individuals is associated with specific changes in the gut microbiota, including decreased bacterial diversity and shifts in the abundance of key microbial genera. Differences were found between age groups and regions. This review highlights a clear association between gut microbiota composition and obesity in the Mexican population. Further research is essential to investigate how the traditional Mexican diet may influence gut health and serve as a potential tool to treat obesity.

3 August 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
RPRogelio Paniagua-Pérez
Rogelio Paniagua-Pérez
LSLaura Sanchez-Chapul
Laura Sanchez-Chapul
EMEduardo Madrigal-Bujaidar
Eduardo Madrigal-Bujaidar
IÁIsela Álvarez-González
Isela Álvarez-González
EMEduardo Madrigal-Santillán
Eduardo Madrigal-Santillán
AQAlejandra Quintana-Armenta
Alejandra Quintana-Armenta
Pteropodine (PT) is a component of some plants with potentially useful pharmacological activities for humans. This compound has biomedical properties related to the modulation of the immune system, nervous system, and inflammatory processes. This study addresses the anti-inflammatory and antioxidant capacity of pteropodin in a murine model of arthritis and induced edema of the mouse ear. To evaluate the anti-inflammatory activity, we used the reversed passive Arthus reaction (RPAR), which includes the rat paw edema test, the rat pleurisy test, and a mouse ear edema model. The antioxidant effect of PT was evaluated by determining the myeloperoxidase enzyme activity. PT showed an anti-inflammatory effect in the different specific and non-specific tests. We found a 51, 66 and 70% inhibitory effect of 10, 20 and 40 mg/kg of PT, respectively, in the rat paw edema test. In the pleurisy assay, 40 mg/kg of PT induced a low neutrophil count (up to 36%) when compared to the negative control group, and 20 mg/kg of PT increased the content of lymphocytes by up to 28% and the pleural exudate volume decreased by 52% when compared to the negative control group, respectively. We also found an 81.4% inflammatory inhibition of the edema ear with 0.04 mg/ear of PT, and a significant myeloperoxidase enzyme inhibition by the three doses of PT tested. We conclude that PT exerted a potent anti-inflammatory effect in the acute inflammation model in rodents.

29 November 2022 in Toxics
Verified
Journal Article
Open access
PDF file
EMEduardo B. Madrigal-Bujaidar
Eduardo B. Madrigal-Bujaidar
RPRogelio Paniagua-Pérez
Rogelio Paniagua-Pérez
MRMichael Joshue Rendón-Barrón
Michael Joshue Rendón-Barrón
JMJose A. Morales-González
Jose A. Morales-González
EMEduardo Madrigal-Santillán
Eduardo Madrigal-Santillán
IAIsela Alvarez-Gonzalez
Isela Alvarez-Gonzalez
Venlafaxine is an antidepressant used worldwide. Therefore, studies to confirm its safe use are mandatory. This report evaluated the drug DNA damage capacity in the brain and liver of ICR mice, and its oxidative effect on DNA, lipids, and proteins, as well as the amount of nitrites, also in the brain and liver. Determinations were made at 2, 6, 12, and 24 h post-treatment, excluding DNA oxidation that was observed at 2 h. The tested doses of venlafaxine were 5, 50, and 250 mg/kg. The results showed DNA damage in the brain with the two more elevated doses of venlafaxine at 2 and 6 h post-treatment and also at 12 h in the liver. The comet assay plus the FPG enzyme showed DNA damage in both organs with all doses. The two high doses increased lipoperoxidation in the two tissues from 6 to 12 h post-administration. Protein oxidation increased with the three doses, mainly from 2 to 12 h, and nitrite content was elevated only with the high dose in the liver. The drug was found to affect both tissues, although it was more pronounced in the liver. Interestingly, DNA oxidative damage was observed even with a dose that corresponds to the therapeutic range. The clinical relevance of these findings awaits further investigations.